GlassScriptPhysician profile
Charles R Routh
NPI 1437129798
$2,963.12
in general payments reported to CMS, 2019-2025
16 companies · $743 in 2025
The $743 reported for 2025 was more than what 80% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $407 · 2020: $98.98 · 2021: $202 · 2022: $382 · 2023: $495 · 2024: $636 · 2025: $743.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,874.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,874.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $566.26 | 2022-2024 | Camzyos |
| Exact Sciences Corporation | $414.96 | 2023-2024 | Cologuard Collection Kit |
| Novo Nordisk INC | $376.46 | 2021-2025 | Wegovy, Ozempic |
| Edwards Lifesciences Corporation | $287.11 | 2025 | Sapien 3 Ultra Resilia |
| Lilly USA, LLC | $173.41 | 2022-2024 | Mounjaro |
| Stryker Corporation | $134.11 | 2025 | Tornier Perform Reversed Augmented Glenoid, Tornier Perform Reversed Glenoid |
| Astrazeneca Pharmaceuticals LP | $125.00 | 2019 | |
| Idorsia Pharmaceuticals US INC | $125.00 | 2023 | Quviviq |
| Janssen Pharmaceuticals, INC | $123.75 | 2021 | |
| Allergan, INC. | $114.99 | 2019 | |
| Pfizer INC. | $99.60 | 2019 | |
| Amarin Pharma, INC. | $98.98 | 2020 | |
| Boston Scientific Corporation | $96.57 | 2025 | Watchman Flx |
| Abbvie INC. | $88.41 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $71.31 | 2023 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $67.20 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Routh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.